Performance Inconsistency of Pulse Oximeters Over Five Years of Clinical Use: A Single-Center Study of Masimo Devices.

IF 5.4
Ashraf Fawzy, Michelle M Qin, Xinyi Sun, Li Yan, Chad H Hochberg, Peter H Dziedzic, Jose I Suarez, Yanxun Xu, John W Jackson, Theodore J Iwashyna
{"title":"Performance Inconsistency of Pulse Oximeters Over Five Years of Clinical Use: A Single-Center Study of Masimo Devices.","authors":"Ashraf Fawzy, Michelle M Qin, Xinyi Sun, Li Yan, Chad H Hochberg, Peter H Dziedzic, Jose I Suarez, Yanxun Xu, John W Jackson, Theodore J Iwashyna","doi":"10.1093/annalsats/aaoag300","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Clinical recognition and treatment of hypoxemia rely on pulse oximetry. Despite general awareness of pulse oximeter shortcomings, clinicians may assume consistent performance across time, models, and batches, an assumption essential for applying clinical trial evidence and guidelines at the bedside.</p><p><strong>Objectives: </strong>Assess whether the difference between the estimated arterial oxygen saturation from a medical-grade Masimo pulse oximeter versus gold-standard concurrent arterial blood gas changed over 5 years of clinical use in intensive care unit (ICU) patients.</p><p><strong>Methods: </strong>Patients with ≥1 concurrent arterial oxygen saturation (SaO2) and pulse oximetry (SpO2) in an ICU with high-frequency vital sign data (SpO2 recorded at 2-second intervals) from 2020-2024 were included. Occult hypoxemia (SaO2<88% with SpO2≥92%), and false hypoxemia (SpO2<88% with SaO2≥92%) were examined by calendar year, as were mean oximeter error (SpO2-SaO2), Accuracy Root Mean Square (Arms, the U.S. Food and Drug Administration (FDA)'s preferred measure), and errors >4% and <-4%. Results were stratified by race/ethnicity as recorded in the electronic medical record. An adjusted linear mixed effects model evaluated calendar-year changes.</p><p><strong>Measurements and main results: </strong>223,145 ABGs in 15,129 patients were analyzed. Occult hypoxemia and overestimation errors >4% decreased while false hypoxemia and underestimation errors <-4% increased several-fold between 2020-2024. Mean oximeter error shifted from overestimation to underestimation by mid-2022. Arms fluctuated and was consistently above 3-3.5%, the FDA's threshold for controlled laboratory testing among healthy volunteers, peaking at end of study. Fluctuation was greatest for SaO2<92% and among non-White patients. By 2024, oximeters underestimated oxygen saturation on average in adjusted models for both Black and White patients with SaO2≥92% and showed relative underestimation among Black versus White patients across SaO2 categories.</p><p><strong>Conclusions: </strong>The accuracy of the tested medical-grade pulse oximeter changed year-to-year at a large hospital compared to concurrent arterial blood gas saturation, potentially complicating safe clinical decision-making and application of evidence-based medicine. Errors of false hypoxemia became more common, threatening different clinical consequences and necessitating different adaptations than errors leading to occult hypoxemia.</p>","PeriodicalId":93876,"journal":{"name":"Annals of the American Thoracic Society","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the American Thoracic Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/annalsats/aaoag300","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Clinical recognition and treatment of hypoxemia rely on pulse oximetry. Despite general awareness of pulse oximeter shortcomings, clinicians may assume consistent performance across time, models, and batches, an assumption essential for applying clinical trial evidence and guidelines at the bedside.

Objectives: Assess whether the difference between the estimated arterial oxygen saturation from a medical-grade Masimo pulse oximeter versus gold-standard concurrent arterial blood gas changed over 5 years of clinical use in intensive care unit (ICU) patients.

Methods: Patients with ≥1 concurrent arterial oxygen saturation (SaO2) and pulse oximetry (SpO2) in an ICU with high-frequency vital sign data (SpO2 recorded at 2-second intervals) from 2020-2024 were included. Occult hypoxemia (SaO2<88% with SpO2≥92%), and false hypoxemia (SpO2<88% with SaO2≥92%) were examined by calendar year, as were mean oximeter error (SpO2-SaO2), Accuracy Root Mean Square (Arms, the U.S. Food and Drug Administration (FDA)'s preferred measure), and errors >4% and <-4%. Results were stratified by race/ethnicity as recorded in the electronic medical record. An adjusted linear mixed effects model evaluated calendar-year changes.

Measurements and main results: 223,145 ABGs in 15,129 patients were analyzed. Occult hypoxemia and overestimation errors >4% decreased while false hypoxemia and underestimation errors <-4% increased several-fold between 2020-2024. Mean oximeter error shifted from overestimation to underestimation by mid-2022. Arms fluctuated and was consistently above 3-3.5%, the FDA's threshold for controlled laboratory testing among healthy volunteers, peaking at end of study. Fluctuation was greatest for SaO2<92% and among non-White patients. By 2024, oximeters underestimated oxygen saturation on average in adjusted models for both Black and White patients with SaO2≥92% and showed relative underestimation among Black versus White patients across SaO2 categories.

Conclusions: The accuracy of the tested medical-grade pulse oximeter changed year-to-year at a large hospital compared to concurrent arterial blood gas saturation, potentially complicating safe clinical decision-making and application of evidence-based medicine. Errors of false hypoxemia became more common, threatening different clinical consequences and necessitating different adaptations than errors leading to occult hypoxemia.

5年临床使用脉搏血氧仪的性能不一致性:Masimo设备的单中心研究。
理由:临床对低氧血症的识别和治疗依赖于脉搏血氧仪。尽管普遍意识到脉搏血氧仪的缺点,临床医生可能会假设在不同的时间、型号和批次中表现一致,这是在床边应用临床试验证据和指南所必需的假设。目的:评估在重症监护病房(ICU)患者临床使用5年后,医学级Masimo脉搏血氧仪与金标准并发动脉血气仪估计的动脉氧饱和度之间的差异是否发生变化。方法:纳入2020-2024年在ICU中动脉血氧饱和度(SaO2)和脉搏血氧饱和度(SpO2)同时≥1且有高频生命体征数据(SpO2每2秒记录一次)的患者。隐匿性低氧血症(SaO24%)及测量和主要结果:分析15129例患者的223145个ABGs。结论:与同期动脉血气饱和度相比,某大型医院被测医用级脉搏血氧仪的准确性每年都在变化,这可能使临床安全决策和循证医学的应用复杂化。假性低氧血症的错误比隐匿性低氧血症的错误更常见,威胁着不同的临床后果,需要不同的适应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书